PULMONARY SURFACTANT is a mixture of lipids and proteins that line the alveoli of the lung and function to lower surface tension at the air-liquid interface, promoting even ventilation and preventing lung collapse. The major lipid component of pulmonary surfactant is phosphatidylcholine (PC), with a predominance of dipalmitoylphosphatidylcholine (DPPC), while surfactant protein-A (SP-A) is the most abundant surfactantassociated protein. SP-A is composed of eighteen 28-to 34-kDa subunits forming a 650-kDa octadecamer (50) . Alveolar surfactant levels are strictly regulated by a balance between secretion (production and release) by type II pneumocytes and clearance (reuptake, resecretion, or degradation) by type II cells and macrophages (17) . Both actin-and clathrindependent pathways are responsible for endocytosis of phospholipid-labeled liposomes by alveolar type II cells in intact lung, and secretagogue exposure stimulated liposome uptake via both pathways (42) . Although actin plays a role in clathrin-dependent pathways, some actin-mediated pathways such as phagocytosis, macropinocytosis, and bulk membrane retrieval are clathrin independent. In type II cells, we determined that the turnover of specialized membrane patches containing the lamellar body membrane ABCA3 was sensitive to the actin inhibitor cytochalasin D but not affected by clathrin inhibitors (4) .
Clathrin-dependent pathways often involve specific receptorprotein interactions. SP-A plays an important role in surfactant lipid turnover in isolated type II pneumocytes, as this protein affects cellular secretion, uptake, and recycling of phospholipid (1, 15, 18, 20, 36) . Secretagogues that stimulate phospholipid secretion also were found to enhance SP-A-mediated uptake of phospholipids (1, 19, 29) . Clearance of SP-A from the lungs occurs via a classical receptor-mediated clathrin-coated pit pathway as uptake of SP-A by the lung was sensitive to clathrin inhibitors and gold-labeled SP-A was shown to bind to type II cells in coated plasma membrane invaginations (30, 43) . Several candidate SP-A receptors on the surface of type II cells have been described, including the transmembrane protein P63 (13, 24, 33, 46, 47) . Since secretagogue treatment enhanced calcium-dependent SP-A binding and recruitment of SP-A receptors to the type II cell membrane (11) , it has been proposed that SP-A enhancement of phospholipid uptake occurs through this clathrin-dependent mechanism. Due to the high affinity of SP-A for surfactant DPPC, an SP-A/DPPC lipoprotein-type complex would interact with an SP-A receptor and be incorporated into type II cells via clathrincoated pits (34) .
The role of SP-A in phospholipid turnover was brought into question in view of the fact surfactant phospholipid metabolism in the SP-A Ϫ/Ϫ mouse did not differ appreciably from wild-type SP-A ϩ/ϩ mice (27, 28, 32) . Lung function, surfactant lipid pool sizes, and clearance of DPPC were similar (27, 31) . However, with physiological challenges that normally enhanced surfactant uptake, such as hyperventilation or secretagogue treatment, the gene-targeted rodent lungs were unable to respond (29) . In view of the importance of the regulation of surfactant pool size, compensation in the clearance pathway by the SP-A gene-targeted mouse lung due to the absence of SP-A was a possibility. We hypothesized that SP-A-independent liposome uptake by the lungs of SP-A Ϫ/Ϫ mice may occur via an actin-dependent cell membrane retrieval pathway (29) . Thus, in the present study, we examined the pathways of surfactant lipid removal from the alveolar space of mouse lungs. We utilized inhibitors of clathrin-mediated and actinmediated endocytosis to follow the uptake of intratracheally instilled labeled DPPC liposomes by the isolated, perfused intact lungs of wild-type and SP-A Ϫ/Ϫ mice. Mice SP-A gene-targeted mice were initially obtained from the University of California, San Francisco (26) . The SP-A Ϫ/Ϫ mice used in this study were the progeny of a breeding colony set up at the University of Pennsylvania (29) . Analysis of SP-A Ϫ/Ϫ mice confirmed the absence of the normal SP-A (26, 29) . Wild-type C57Bl6 mice were obtained from Jackson Laboratories (Bar Harbor, Maine). The mice were between 2-3 mo of age (body wt ϭ 18 -25 g). All procedures utilizing mice were approved by the Institutional Animal Care and Use Committees.
MATERIALS AND METHODS

Materials
Liposome Preparation
Liposomes were prepared from L-␣-DPPC, egg PC, egg phosphatidylglycerol, and cholesterol in molar ratio 10:5:2:3 with or without trace amounts of [ 3 H]DPPC. The lipids were evaporated to dryness under nitrogen. The dried lipids were resuspended in PBS without calcium/magnesium. The mixture was frozen and thawed three times by alternating liquid nitrogen with a 50°C water bath and passed eight times at 50°C through 100 nm pore sized filters using an "Extruder" (Lipex Biomembranes Vancouver, BC). Liposomes were stored at 4°C and used within 24 h. This method resulted in unilamellar liposomes of 103 Ϯ 8 nm (mean Ϯ SE; n ϭ 4) as assessed by light scattering using a 90Plus particle size analyzer (Brookhaven Instruments).
Isolated Lung Perfusion
Mice were anesthetized with intraperitoneal pentobarbital sodium (50 mg/kg body wt). The mice then were continuously ventilated, the thorax was incised, and the lungs were cleared of blood by perfusion through the pulmonary artery with buffer [Krebs' Ringer bicarbonate pH 7.4, with 3% BSA (KRB)]. The total isolation procedure required ϳ5 min. Isolated lungs were perfused with KRB containing 10 mM glucose in a closed circuit recirculating perfusion apparatus similar to that described previously for rat lungs (22) . Lungs were perfused for 2 h with buffer alone (control) or with buffer containing 8-Br-cAMP (0.1 mM, stimulated), 10 mM amantadine, or 10 M cytochalasin D. Perfusate was gassed constantly with 5% CO 2 in air. Lungs were ventilated at 60 cycles/min, 0.3 ml tidal volume, and 2 cm H2O end-expiratory pressure. There was no significant change in the ventilation and perfusion pressures or overt evidence of lung edema during the experiments.
DPPC Uptake: Isolated Perfused Lung
To measure DPPC uptake, the trachea of anesthetized mice was cannulated. [ 3 H]DPPC-labeled liposomes (10 nmol DPPC in 20 l saline) were instilled into the lungs with a Hamilton syringe inserted into the trachea through the cannula to the level of carina. Then the lungs were perfused as described above. At the end of the ϳ5-min period required for lung isolation (baseline) or the 2-h experimental perfusion, lungs were lavaged five times with 1-ml aliquots of ice-cold saline. Lung tissue was then homogenized in saline on ice by using a Polytron homogenizer followed by a motorized mortar and pestle. Lipid fractions from the lung homogenate were extracted using the Bligh and Dyer procedure (6 Distribution of the instilled liposomes in the mouse lung using the described protocol was determined. Twenty microliters of [ 3 H]DPPC labeled liposomes (380,900 dpm) were instilled into each of two mouse lungs as described, and the lung perfusions were terminated after 15 min. The right and left lung lobes from each mouse were cut into 10 small segments per lobe (40 segments total), extracted, and analyzed for radioactivity and protein (8) . For the two mice, 92 and 94% of the instilled [ 3 H]DPPC was recovered from the lungs. The trachea and extra-pulmonary bronchi contained Ͻ2% of the total radioactivity in both cases. The radioactivity was equally divided between the right and left lungs with each containing 45.7 Ϯ 0.5% (mean Ϯ SE; n ϭ 4) of the liposomes instilled. The 40 segments each contained 17,597 Ϯ 385 dpm/mg protein or 4.6 Ϯ 0.1% of instilled liposomes (mean Ϯ SE-n ϭ 40) with a range of 11,134 to 22,164 dpm/mg protein or 2.9 to 5.6% of instilled liposomes. The results indicate that the liposomes were distributed relatively evenly throughout the mouse pulmonary tissue.
Surfactant Secretion: Isolated Perfused Lungs
Measurement of surfactant secretion from isolated mouse lungs was performed essentially as described for isolated rat lungs (9) . Mouse lungs were perfused for 30 min with KRB buffer (pH 7.4) containing 10 Ci [ 3 H]choline to label the lung PC. At the end of labeling period, 50-fold of excess unlabeled choline was added to the perfusion medium. Some perfusions were terminated at this stage to get zero time secretion data. Other lungs were perfused for 2 h with or without 1 mM ATP. Lungs were lavaged with 5 ϫ 1 ml of cold saline, and the cell free lavaged fluid and postlavaged lungs were analyzed for radioactivity (6) .
Isolation of Type II Cells
Type II cells were isolated from adult C57/BL6 wild-type or SP-A knockout (KO) mouse lungs using the previously described procedure of Bortnick et al. (7) that was modified from Warshamana et al. (49) . After digestion of the lungs with dispase and treatment with DNase I, the cells from five sets of lungs were pooled, filtered through nylon mesh, and panned on mouse IgG-coated Petri dishes to remove macrophages. The nonadherent cells were seeded on 100-mm cell culture dishes at 37°C for 1 h in MEM with 10% FBS to remove fibroblasts. The final cell isolates were placed on type I collagencoated 35-mm dishes in Ham's F-12 culture medium supplemented with 15 mM HEPES, 0.8 mM CaCl 2, 0.25% BSA, 5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml sodium selinite, and 2% mouse serum. After 24 h, the medium was changed to serum-free Ham's F-12 with the same additions as above. The isolated type II cells were Ͼ95% pure after 24 h in culture (7) as judged by cytokeratin staining and the presence of Nile red positive vacuoles.
Isolation and Iodination of SP-A
SP-A was purified from bronchoalveolar lavage fluid of alveolar proteinosis patients after therapeutic lavage at the Hospital of the University of Pennsylvania as described previously (1) using the method of Hawgood et al. (25) . Endotoxin levels in SP-A preparations were 0.5 pg endotoxin/g SP-A protein as measured by the Limulus Amebocyte Lysate Test performed by Lonza (Waldersville, MD). Iodination of SP-A was performed using Iodogen (Pierce, Rockford, IL) using the manufacturer's directions. One-hundred micrograms of SP-A were iodinated with 100 Ci of Na 125 I. Iodinated protein was dialyzed against 5 mM Tris buffer for 24 h with frequent buffer changes to remove free 125 I. Specific activity for all preparations was ϳ50 -70 cpm/ng protein. The TCA precipitability ranged from 90 to 97%. The iodinated proteins were stored at 4°C and were used within 2-3 wk.
SP-A Binding by Type II Cells
After overnight culture, cells were placed on ice and washed two times with ice-cold MEM and once with MEM containing 0.1% fatty acid free BSA. Cells then were incubated at 4°C for 1 h with various concentrations of 125 I-SP-A. To terminate the experiment, the media were removed and the cells were washed once with MEM ϩ 0.3% fatty acid free BSA, twice with MEM ϩ 0.1% fatty acid free BSA and twice with PBS. Cells were dissolved in 0.2 N NaOH, and aliquots taken for protein determination (39) and radioactive counts (Beckman).
PC Secretion
After isolation, type II cells were incubated overnight with 0.5 Ci/dish of [methyl-
3 H]choline in MEM containing 10% FCS to label cellular phospholipids. Cells were washed extensively and incubated for 30 min in MEM. One set of cells was harvested and served as control for phospholipid secretion associated with the medium change, as described previously (2) . The remaining cells were preincubated with or without SP-A (1.0 g/ml, 15 min), followed by addition of adenosine triphosphate (1 mM ATP, Sigma, St. Louis, MO) for 2 h. The media were removed and centrifuged to remove detached cells. Methanol was added to the cell monolayer, and the cells were scraped from the dish. The cells and the media were extracted using the Bligh and Dyer method (6) . The amount of phospholipid secretion was calculated as the percentage of lipid counts per minute in the medium, relative to the total counts per minute lipid present in the cells plus the medium. All experiments were performed in duplicate or triplicate, and the values were averaged.
Statistical Analysis
Results are reported as means Ϯ SE unless otherwise stated. Results were analyzed statistically by t-test or paired t-test using SigmaStat for Windows (Jandel, San Rafael, CA) where statistical significance is taken as P Ͻ 0.05. Multiple group comparisons were done by one-way ANOVA with Bonferroni's correction. When SE bars are not visible in the figures, they are contained within the symbols.
RESULTS
SP-A Regulation of Surfactant Uptake in the Intact Lung
Using the SP-A gene-targeted mouse, we have shown that basal uptake of liposomes into the lung was similar between wild-type and SP-A gene-targeted mice, while the presence of SP-A was necessary for the increased clearance of alveolar DPPC liposomes after secretagogue treatment (29) . To characterize the endocytic pathways involved, we adapted procedures previously utilized in isolated, perfused rat lungs to this mouse system (42) . Amantadine is a cationic amphiphilic agent that prevents budding of clathrin-coated vesicles and is used to block clathrin-mediated processes. Cytochalasin D is an agent that destabilizes the actin cytoskeleton and inhibits actinmediated endocytosis. In previous studies using amantadine and cytochalasin D, we demonstrated that both clathrin-mediated and actin-mediated pathways were utilized for endocytosis of DPPC-labeled liposomes by granular pneumocytes in the intact rat lung, while SP-A was cleared from the rat lung by a clathrin-mediated pathway that required the polymerization of actin (30, 42) .
Inhibition of the uptake of intratracheally instilled labeled liposomes by amantadine and cytochalasin D in wild-type (SP-A ϩ/ϩ) and SP-A gene-targeted (SP-A Ϫ/Ϫ) mouse lungs was examined under unstimulated (basal) or cAMP-stimulated conditions. The recovery of [
3 H]DPPC-labeled liposomes from the lung at the end of the 2-h experiment is shown in Figure 1 . Table 1 documents the amount of liposome clearance inhibited by the drug treatment and was determined by subtraction of the residual [ 3 H]DPPC liposome uptake that occurred in the presence of inhibitors from that which occurred without inhibition (control). As reported previously, under unstimulated basal conditions, uptake of [ Table 1 ). However, blocking just the clathrin-mediated pathway using amantadine alone in wild-type mice reduced liposome uptake 70%, while having only a minimal effect (19%) on liposome clearance in the SP-A Ϫ/Ϫ mice.
Since actin plays a role in clathrin-mediated uptake processes (23, 37, 42) , the contribution of actin polymerization to pathways of liposome uptake that were independent of coatedpit formation (nonclathrin, actin-dependent) was determined by subtraction of the amantadine-sensitive liposome incorporation (clathrin-dependent) from that found with both amantadine and cytochalasin D present (clathrin-and actin-dependent; Table 1 ). The nonclathrin, actin-dependent pathway was responsible for 55% of the liposome uptake in SP-A Ϫ/Ϫ mice but only 3.5% in wild-type mice lungs. Thus, for the clearance of liposomes by the lung, the clathrin-mediated pathway predominates in the wild-type mice and the nonclathrin, cytochalasin D-sensitive pathway predominates in the SP-A Ϫ/Ϫ mice.
Uptake of liposomes into the lungs of SP-A Ϫ/Ϫ mice is unresponsive to secretagogue treatment unlike the stimulatory effect on liposome clearance seen in SP-A ϩ/ϩ mice (29) . Those observations were reconfirmed by the experimental data in Fig. 1B and Table 1 where the total uptake of liposomes with cAMP increased by 1.9-fold over basal conditions in the wild-type mice with no effect in the SP-A Ϫ/Ϫ mice. Both the amantadine (clathrin) and cytochalasin D (actin)-sensitive pathways in the wild-type mice were stimulated due to secretagogue treatment with the former making a larger contribution.
Inclusion of both amantadine and cytochalasin D in the perfusate reduced liposomal PC incorporation into cAMP-stimulated SP-A ϩ/ϩ or SP-A Ϫ/Ϫ lung tissue from 10.5% or 5.6% of instilled, respectively, to ϳ2% of instilled in both groups of mice (Fig. 1B) , blocking 82 or 63% of instilled liposomes in wild-type or SP-A Ϫ/Ϫ mice, respectively (Table 1 ). In the SP-A Ϫ/Ϫ mice there were no significant changes in either the clathrin-or actin-sensitive pathways with cAMP present ( Fig.  1 ; Table 1 ). Thus, amantadine-sensitive liposome uptake increases 1.7-fold in the wild-type mice from 4.0% to 7.0% of instilled liposomes and remained unchanged in the SP-A Ϫ/Ϫ mice ( Table 1) .
The contribution of actin polymerization to the liposome uptake process in these experiments was determined by subtraction (Table 1) . To confirm the role of actin in a clathrinindependent pathway as well as confirm an actin contribution to the coated pit system, cytochalasin D was added to the perfusate of the mouse lungs under all experimental conditions. The data in Fig. 1 and Table 2 indicate that the actin-mediated pathway functioned independently from both the presence of SP-A and the stimulatory effect of cAMP as the addition of cytochalasin D alone blocked 60 -70% of liposome clearance under all experimental conditions.
SP-A Regulation of Surfactant Secretion in the Isolated, Perfused Lung and in Primary Cultures of Mouse Pneumocytes
Isolated perfused lung. Since surfactant clearance from the SP-A Ϫ/Ϫ mice lungs was unresponsive to secretagogue treatment, we determined whether secretion of surfactant was similarly affected. Surfactant PC secretion from the lungs of SP-A ϩ/ϩ and -/-mice after perfusion with [ 3 H]choline for 2 h was examined. The amount of PC synthesis ([ 3 H]choline incorporation into PC) that occurred over this time period did not differ with genotype or secretagogue treatment (Table 3) . Secretion is expressed as the percentage of the total [
3 H]PC (lung tissue plus lavage) that is found in the lavage itself (10, 21) after a subsequent 1-h period. As shown in Fig. 2A and Table 4 , the wild-type mouse lung responded to secretagogue treatment (1 mM ATP) with an approximately twofold increase in release of PC. While the SP-A KO mice responded to ATP treatment in a similar fashion as the wild-type mice, surfactant secretion was significantly higher than that seen with wild-type mice lungs under both basal and stimulated conditions ( Fig.  2A ; Table 4 ).
Mouse type II cells. To confirm that type II cells were responsible for the observed changes, mouse type II cells were isolated from wild-type and SP-A Ϫ/Ϫ mice and surfactant PC labeled by overnight incubation with [ 3 H]choline. As shown in Fig. 2B and Table 4 , basal PC secretion from wild-type mouse type II cells was stimulated by ATP and both basal and stimulated secretion were inhibited by SP-A exposure, data reflecting the results of ourselves and others using rat type II cells (14, 40, 48) . As seen with the isolated lung, the type II cells from SP-A Ϫ/Ϫ mice in culture responded to secretagogue treatment. In addition, both basal and stimulated PC secretion from the SP-A Ϫ/Ϫ mice type II cells was 90% and 60% higher than the cells from SP-A ϩ/ϩ mice. The results in Table 4 demonstrate that the measurements of PC secretion determined using type II cells in culture reflected that seen with the isolated lung. Exposure of the type II cells from wild-type mice to SP-A blocked both basal and stimulated PC secretion. It was of interest that incubation of the pneumocytes from the SP-A Ϫ/Ϫ mice with SP-A also inhibited basal and ATPstimulated PC secretion, consistent with the presence of SP-A receptors on these cells from SP-A Ϫ/Ϫ mice although the cells had never been exposed to SP-A in vivo.
Binding of 125 I-SP-A to Mouse Type II Cells
To determine the status of SP-A binding proteins on the type II cells from SP-A Ϫ/Ϫ mice, binding and uptake studies were performed using 125 I-SP-A. Type II cells isolated from the lungs of SP-A ϩ/ϩ or SP-A Ϫ/Ϫ mice were incubated at 4°C for 1 h with increasing concentrations of iodinated SP-A. (binding plus uptake) of iodinated SP-A in the specific portion of the SP-A binding curve (at 0.5 and 1 g SP-A/ml) showed comparable cell association of SP-A to the mouse pneumocytes regardless of genotype ( Table 5) .
Rescue of the SP-A KO Mouse
Since SP-A binding to the type II cells from SP-A Ϫ/Ϫ mice appeared to be normal, "rescue" experiments were performed to determine whether the clearance of liposomes from the alveolar space of SP-A negative mice could be enhanced by the addition of SP-A to the instilled liposomes. (Fig. 4A) , values comparable to the effect of cAMP on liposome uptake in SP-A ϩ/ϩ wild-type mice (1.8-fold; Table 1 ; Fig. 4B ). In the presence of normal levels of surfactant SP-A, as in the wildtype mouse, the addition of SP-A to the instilled liposomes had no further effect on liposome uptake under either unstimulated or stimulated (cAMP) conditions (Fig. 4B) .
DISCUSSION
Precise coordination of the surfactant content in the alveolar space is required for optimum lung function. In view of the active role of SP-A in the regulation of phospholipid secretion and uptake in cell cultures of type II pneumocytes, it was unexpected that mice lacking SP-A demonstrated normal phospholipid metabolism unless challenged (27) (28) (29) 32 ). Since compensatory mechanisms may have been recruited by the SP-A Ϫ/Ϫ mice, a detailed examination of the mechanisms for surfactant clearance from the lung was performed utilizing the isolated, perfused mouse lung as an experimental model. Using inhibitors of the clathrin-and actin-mediated pathways, we demonstrated that the clathrin-mediated pathway, presumably involving uptake of DPPC/SP-A complexes via an SP-A receptor, was principally responsible for clearance of surfactant DPPC liposomes from the wild-type (SP-A ϩ/ϩ) mouse lung while actin-mediated endocytosis predominated in SP-A Ϫ/Ϫ mice. In wild-type mice, secretagogue treatment elevated DPPC liposome uptake primarily through an increase in the clathrin-mediated route. Knockout of SP-A eliminated the ability of the mouse lung to respond to secretagogues, data that emphasize the importance of SP-A for enhanced surfactant clearance by the lung. Binding of SP-A to isolated pneumo- Data are the uptake of ͓ 3 H͔dipalmitoylphosphatidylcholine (͓ 3 H͔DPPC) liposomes by the perfused lung in the absence (basal conditions) or presence (cAMP-stimulated conditions) of 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-Br-cAMP; 0.1 mM) that were inhibited by amantadine or cytochalasin D. Experiments were performed as described in Fig. 1 . Results are expressed either as "%instilled" or as "%total uptake." Each value is the mean Ϯ SE for n ϭ See Table 1 and Fig 1 for details. (A) Data taken from Table 1 . *Significant difference from SP-A ϩ/ϩ, P Ͻ 0.05; n ϭ 3-5 lungs. H͔choline Ϯ ATP (1 mM) and lavaged, and lung tissue and lavage were extracted for lipid. Phosphatidylcholine (PC) synthesis data in both fractions were combined for total lung PC synthesis.
cytes was similar irrespective of the SP-A gene status of the source of the lung used for cell isolation, which are data consistent with the presence of normal levels of SP-A binding proteins in the SP-A Ϫ/Ϫ mice lungs. Addition of SP-A to the liposomes before instillation "rescued" the SP-A Ϫ/Ϫ mice and confirmed the presence of active SP-A receptors. Lung clearance of the liposome/SP-A complex was elevated over preparations with lipid alone under basal conditions and uptake of the complex now responded to secretagogue stimulation. Figure 5 summarizes the contribution of the various pathways to the clearance of liposomes from the lungs of the two mice genotypes. Uptake that was not inhibited by amantadine or cytochalasin D (neither, Fig. 5 ) was an unidentified pathway that remains fairly constant under all situations and may represent DPPC adsorbed to the surface of the lung past the initial 5-min period (42) . Under basal conditions, it is apparent that the clathrin-mediated pathway, presumably via SP-A/ DPPC receptor interactions, was responsible for the bulk of the lipid uptake in the SP-A ϩ/ϩ mice. To determine the fractional contribution of SP-A to liposome clearance, we subtracted the amantadine-sensitive liposome uptake in the SP-A Ϫ/Ϫ mouse lung (clathrin-mediated lipid uptake that occurs in the absence of SP-A) from the amantadine-sensitive liposome uptake in the wild-type mouse. The results indicate that 75% of the clathrin-mediated uptake of liposomes was mediated by SP-A under basal situations and 81% under stimulated conditions in the wild-type mice. Both clathrin-mediated and nonclathrin, actin-mediated pathways were stimulated with secretagogue addition, but the majority of liposome clearance utilized the clathrin dependent receptor-mediated process. In the absence of SP-A (SP-A Ϫ/Ϫ mice) the nonclathrin, actin-mediated pathway predominated under basal and stimulated conditions. As demonstrated in rats (42) , the present study in mice reconfirms the presence of both clathrin-and actin-dependent pathways that account for ϳ65% or more of the lipid uptake.
The results are compatible with the interpretation that the SP-A gene-targeted mice have compensated for the lack of SP-A and the inability to use the SP-A receptor-mediated pathway by up-regulating a nonclathrin, actin-sensitive endo- Fig. 2 . In SP-A Ϫ/Ϫ vs. SP-A ϩ/ϩ, SP-A ϩ/ϩ ϭ 100%. In ATP vs. control, control ϭ 100%. All values are statistically significantly different from 100% (see Fig. 2 for raw data), P Ͻ 0.05. The remaining dishes were incubated Ϯ SP-A (1 g/ml, 15 min), followed by ATP (1 mM) for 2 h. Data are mean Ϯ SE expressed as %PC secretion. A: data are dpm in the lavage/total dpm (lung plus lavage); n ϭ 3. B: data are dpm in the media/total dpm (cell plus media) ϫ 100; n ϭ 4. P Ͻ 0.05 vs.
a control or b SP-A ϩ/ϩ.
cytic mechanism to maintain normal levels of surfactant lipid uptake. However, the latter pathway may have a limited capacity and be operating at a maximum rate in the SP-A Ϫ/Ϫ mice as it could not be enhanced further by secretagogue treatment. The lack of response to secretagogues was not due to the insensitivity of actin-sensitive uptake mechanism to secretagogue stimulation because when this nonclathrin-actin sensitive route was low, as seen under basal conditions in the wild-type mice (0.2% of instilled liposomes), it could be enhanced 8-fold after 2 h of exposure to cAMP (1.6% of instilled; Figure 5 ). Although up-regulation of the nonclathrin, actin-mediated pathway in wild-type mice upon exposure to secretagogues was rapid (2 h), it appears that 2 h was not a sufficient length of time to down-regulate the actin pathway in the SP-A Ϫ/Ϫ mice. Upon instillation of the SP-A/liposome complex in the "rescue" experiments, the increase in the amount of liposome uptake (9.1% of instilled (5, 38) . Our current and previous data on the mechanism for clearance of surfactant were consistent with actin contributing to clathrin-mediated lipid incorporation into the lung since the inhibitory effects of amantadine and cytochalasin D in combination (4.2% of instilled) were not the sum of each drug alone [amantadine (4.0% of instilled) plus cytochalasin D (3.8% of instilled) equals 7.8% of instilled]. Thus, the effects of the inhibitor cytochalasin D were not solely on actin-mediated pathways but also on clathrin-mediated pathways, complicating the interpretation of the cytochalasin D data. To determine the contribution of the actin-dependent but clathrin-independent pathway, we subtracted the amount of lipid uptake inhibited by amantadine and cytochalasin D instilled together from that by amantadine alone, termed the "nonclathrin, actin-dependent" pathway. To confirm an effect of actin-polymerization on liposome uptake, we used cytochalasin D alone. The extent of the inhibition of liposome uptake in the presence of cytochalasin D alone was the same or greater Table 1 are summarized. "Clathrin-mediated" data are from the amantadine-treated mice. "Nonclathrin, actin-mediated" data are derived from the subtraction of the amantadine-sensitive liposome uptake from that sensitive to both amantadine and cytochalasin D (see Table 1 ). "Neither" data reflect the liposome uptake that was not inhibited by either agent. than that attributed to the nonclathrin, cytochalasin D-sensitive pathway. The results confirm the findings from our laboratory and others that actin filaments make an important contribution to clathrin-mediated endocytosis (5, 23, 42 ). The precise nature of the clathrin-independent actin-sensitive pathway of liposome uptake into the lung was not examined in further detail. However, the polymerization of the actin network plays a role in several endocytic pathways including two that are sensitive to secretagogues, lipid rafts and lamellar body membrane retrieval. Caveolae are considered to be lipid rafts enriched in cholesterol, glycosphingolipids, sphingomyelin, glycosylphosphatidylinositol-linked proteins, and several other proteins including caveolin and flotillin. Although type II cells lack caveolin 1, flotillin-positive lipid rafts have been isolated from type II cells, were found to play a role in surfactant secretion, and were sensitive to secretagogues (12) . With the observed coordination between secretion and reuptake (16) , lipid rafts may function in surfactant uptake as well. We have previously examined the retrieval of plasma membrane patches that contain ABCA3, a 180-kDa protein that is associated with lamellar body membranes (52) . ABCA3 is expressed on the cell surface of the rat type II cell after secretion in association with membrane patches that were subsequently endocytosed in small vesicles and fused with existing lamellar body organelles inside the cell (45) . NBD-PC liposomes added to the type II cells in culture are reinserted in the same intracellular compartment as ABCA3, the lamellar body (44) . Using monoclonal antibody 3C9 that recognizes ABCA3, we followed trafficking of lamellar bodies and determined that stimulation of secretion enhanced the appearance and retrieval of ABCA3 from the surface of the type II cell. This pathway required the active participation of actin since it was inhibited by cytochalasin D but was insensitive to inhibitors of clathrin-mediated endocytosis (3) .
Our data on the synthesis of PC using the incorporation of [ 3 H]choline into the PC of the isolated perfused mouse lung after 2 h of perfusion agree with those of Ikegami et al. (27) who followed the incorporation of [ 3 H]choline or [ 14 C]palmitate into saturated PC in lung slices. Both groups showed no difference in lung PC synthesis between wild-type and SP-A Ϫ/Ϫ mice. We found significantly more (35-90% greater) secretion of PC from isolated, perfused lungs, and isolated type II cells from SP-A Ϫ/Ϫ mice than wild-type mice. Such data support a role for SP-A in the inhibition of surfactant secretion. In contrast to our results, the previous study found no significant difference between SP-A ϩ/ϩ and SP-A Ϫ/Ϫ mice in DPPC secretion (27) . This latter result may reflect the relative difficulty in the study of surfactant secretion in intact mice where compensatory mechanisms may overshadow the primary effects. In any case, it is clear from our data that PC secretion from type II pneumocytes isolated from either wildtype or SP-A Ϫ/Ϫ mice are sensitive to the presence of SP-A. Basal and stimulated PC secretion was inhibited by exposure to SP-A in pneumocytes from either source. Since it is well established that the ability of SP-A to regulate secretion requires SP-A-receptor interactions, the data imply that the level of SP-A receptors is normal in both cases and binding studies utilizing iodinated SP-A confirmed the equivalent status of the SP-A receptor.
The binding kinetics of SP-A to wild-type mouse type II cells were similar to those seen with rat type II cells (1, 35, 51) . In the SP-A Ϫ/Ϫ mice lungs, instillation of an SP-A/liposome complex resulted in enhanced lung internalization of surfactant liposomes and recovery of sensitivity to secretagogue challenge through increased lipid clearance, uptake that was similar to that previously seen in the SP-A ϩ/ϩ mice. The data indicate an important role for the uptake of an SP-A/DPPC complex via clathrin-(and presumably SP-A receptor-) mediated endocytosis in wild-type mice. Further studies will determine whether the putative SP-A receptor we have recently described, P63, plays a role in mediating the uptake of SP-A/DPPC lipoprotein-like liposomes (24) .
In the absence of SP-A, there remained a minor amantadinesensitive liposome uptake pathway in SP-A Ϫ/Ϫ mice (19% of total uptake). This clathrin-mediated clearance of liposomes was unaffected by secretagogue exposure. There are several possible reasons for this finding including association of other surfactant proteins with the liposomes and utilization of different receptor-mediated, clathrin-sensitive pathways (31) . SP-B and SP-C have been reported to stimulate liposome uptake by type II cells in culture although the uptake was not saturable, data that would not be compatible with receptormediated events (41) . In addition, since both alveolar macrophages and type II cells could contribute to all of the observed findings, studies on the role of the macrophages in surfactant clearance are necessary to fully define possible mechanisms involved in this alternate pathway.
In summary, the SP-A-dependent clathrin-mediated pathway was of major importance for the uptake of phospholipid from the isolated perfused lung of wild-type mice. In the absence of this pathway due to deletion of SP-A, an actin-dependent pathway is utilized, which is insensitive to the physiologic challenge of secretagogue treatment. Thus, SP-A is necessary for the normal clearance of surfactant lipid from the alveolar space. Characterization of the interaction of SP-A with the SP-A receptor will be important to further the understanding of the regulation of surfactant turnover.
